URICA THERAPEUTICS
Urica Therapeutics is a clinical-stage biopharmaceutical company focusing on the development and commercialization of pharmaceutical products to treat gout and chronic kidney diseases. Urica is a subsidiary company of Fortress Biotech.
URICA THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Life Science Medical
Founded:
2021-01-01
Address:
Miami, Florida, United States
Country:
United States
Website Url:
http://www.uricatherapeutics.com
Total Employee:
1+
Status:
Active
Total Funding:
2.53 M USD
Similar Organizations
Athersys
Athersys is a biopharmaceutical company that discovers and develops therapeutic products to treat several disease indications.
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
Prolocor
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapyโbased treatments for cardiovascular disease.
Official Site Inspections
http://www.uricatherapeutics.com
- Host name: cust-155.130.138.30.switch.com
- IP address: 155.130.138.30
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Urica Therapeutics"
About Us โ Urica Therapeutics
Urica is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of pharmaceutical products to treat gout.See details»
Management Team โ Urica Therapeutics
24 years as CEO of 2 public companies (with 2 rheumatology product approvals), and most recently led Pfizerโs External R&D Innovation group and R&D Innovate venture fundSee details»
Urica Therapeutics Company Profile | Management and ... - Datanyze
Www.uricatherapeutics.com Urica Therapeutics Profile and History Urica Therapeutics, Inc. ("Urica") is a clinical-stage biopharmaceutical company that focuses on the development and โฆSee details»
Urica Therapeutics, Inc. | LinkedIn
Urica Therapeutics, Inc. (โUricaโ) is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of pharmaceutical products to treat gout and other ...See details»
Urica Therapeutics - Crunchbase Company Profile & Funding
Urica Therapeutics is a clinical-stage biopharmaceutical company focusing on the development and commercialization of pharmaceutical products to treat gout and chronic kidney diseases.See details»
Urica Therapeutics - PitchBook
Www.uricatherapeutics.com. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. 1111 Kane Concourse; Suite 301; Bay Harbor Islands, FL 33154; United States +1 (781) โฆSee details»
Urica Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Uricatherapeutics.com. Startups | Subsidiary Company | 2021 | Florida, United States | < 10 | uricatherapeutics.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. Translational โฆSee details»
Urica Therapeutics Announces Topline Data from the Phase 1 โฆ
Jun 29, 2023 Jay D. Kranzler, M.D., Ph.D., Uricaโs Chairman and Chief Executive Officer, said, โWe are encouraged that the data from our Phase 1 clinical trial in U.S. healthy volunteers โฆSee details»
Urica Therapeutics, Inc. Staff Directory & Email Format - ContactOut
Explore Urica Therapeutics, Inc. staff directory for direct access to contact details on 1 employees including email format, email address and phone numbers.See details»
Investors & Media โ Urica Therapeutics
Urica Therapeutics is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of pharmaceutical products to treat gout and chronic โฆSee details»
Urica Therapeutics - Work in biotech
Urica Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative treatments for gout and other conditions associated with hyperuricemia. Their lead โฆSee details»
Urica Therapeutics - VentureRadar
Website: https://uricatherapeutics.com/ Urica is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of pharmaceutical ...See details»
Urica Therapeutics - Overview, News & Similar companies
Who is Urica Therapeutics. Urica Therapeutics, Inc. ("Urica") is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of pharmaceu tical products โฆSee details»
Urica Therapeutics - Company Profile - Tracxn
Oct 11, 2024 Urica Therapeutics ranks 66th among 66 competitors. 18 of its competitors are funded while 5 have exited. Overall, Urica Therapeutics and its competitors have raised over โฆSee details»
Corporate Presentation โ Urica Therapeutics
Check back soon for updates. Home; About Us; Pipeline; Clinical Trials; Business Development; 2023 URICA THERAPEUTICS. ALL RIGHTS RESERVED. PRIVACY POLICYSee details»
home - Oliva Therapeutics
Our privacy policy oliva therapeutics, llc (oliva) recognizes the importance of privacy and security in today's technological world. with that in mind, oliva will never ask or use personal information.See details»
Press Releases โ Urica Therapeutics
Oct 3, 2022 Urica Therapeutics Expands Exclusive License Agreement with Fuji Yakuhin Co. Ltd. to Develop Dotinurad in Additional Territories Including Turkey and the Middle East and โฆSee details»
Urica Therapeutics, Inc. (Urica Therapeutics, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ โฆ
A open label multi-center 3-period multidose, PK/PD and drug-drug interaction (DDI) study to evaluate the pharmacokinetics (PK) and pharmacodynamics (PD) of 7 days of treatment with โฆSee details»
Pipeline โ Urica Therapeutics
Dotinurad is an oral URAT1 inhibitor approved in Japan with long patent life and has excellent long-term efficacy and safety profiles. Phase 1 trials are currently underway in the U.S., and โฆSee details»